The scrip had closed at Rs 414.25 in the previous session. The stock quoted a 52-week low of Rs 298.05 and a high of Rs 487.7. The company quoted a market-cap of Rs 49698.0 crore on the BSE.
On BSE, 115,984 shares have changed hands on the counter so far. At its prevailing price, the stock traded at 81.38 times its trailing 12-month EPS of Rs 5.09 per share and 4.84 times its book value. The return on equity (ROE) stood at Rs 11.15.
For the quarter ended 31-Dec-2020, Biocon Ltd. reported consolidated sales of Rs 1878.9 crore, up 5.33 per cent from the same quarter a year ago. The company reported 16.86 per cent YoY de-growth in net profit at Rs 168.6 crore for the latest quarter.
The relative strength index (RSI) of the stock stood at Wednesday. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold when it is below 30.
Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a “buy” or “sell” recommendation using a single valuation ratio.